Virtual meeting: Genetic manipulation – potential and
challenges in therapy
Thursday 10th September 2020, 15.00-17.30 via Zoom.
Genetic manipulation has for many years been recognized as an approach to achieve better therapy
for serious and debilitating diseases. With the discovery of the CRISPR/cas technology, efforts in this
field took a major leap. Another efficient strategy includes the use of viral vectors for delivery of gene
therapies. This meeting will provide an introduction to the CRISPR/cas technology and its potential in
future therapies as well as a talk on how to get viral gene therapies from bench to bedside. Finally,
ethical considerations arising with the introduction of gene therapies will be covered.
15:00 – 15:05 Welcome and Introduction
By Mie Kristensen & Hanne Mørck Nielsen, the Danish Pharmaceutical Society
15:05 – 15:50 The CRISPR/cas technology: Potential and challenges in future therapies
By Guillermo Montoya, Professor Novo Nordisk Foundation Centre for
Protein Research, University of Copenhagen
16:10 – 16:55 Viral vectors for delivery of gene therapies: From bench to bedside
By David Paul Drucker Woldbye, Associate Professor, Department of
Neuroscience, University of Copenhagen
16:55 – 17.25 Ethical considerations arising when manipulating with our genes
By Klemens Kappel, Professor, Department of Communication, University of
No entry fee, non-members are also welcoming to participate in the meeting.
SIGN UP IS CLOSED